1. Home
  2. SNTI vs CLRO Comparison

SNTI vs CLRO Comparison

Compare SNTI & CLRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

HOLD

Current Price

$1.10

Market Cap

53.6M

Sector

Health Care

ML Signal

HOLD

Logo ClearOne Inc. (DE)

CLRO

ClearOne Inc. (DE)

HOLD

Current Price

$5.13

Market Cap

10.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNTI
CLRO
Founded
2016
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
53.6M
10.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SNTI
CLRO
Price
$1.10
$5.13
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$9.00
N/A
AVG Volume (30 Days)
4.6M
16.7K
Earning Date
11-13-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$11,386,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$150.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
174.10
52 Week Low
$1.04
$3.83
52 Week High
$5.10
$18.45

Technical Indicators

Market Signals
Indicator
SNTI
CLRO
Relative Strength Index (RSI) 34.92 48.31
Support Level $1.15 $4.60
Resistance Level $1.28 $5.33
Average True Range (ATR) 0.08 0.31
MACD 0.01 -0.02
Stochastic Oscillator 20.00 57.44

Price Performance

Historical Comparison
SNTI
CLRO

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

About CLRO ClearOne Inc. (DE)

ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial products to end-users predominantly through a network of independent distributors, who in turn sell its products to dealers, systems integrators, and other resellers. Its products include DSP mixers, amplifiers, Video walls, professional cameras, and professional microphones among others. Geographically the firm has its business presence across the United States and international markets.

Share on Social Networks: